Labcorp (LH) said Monday that Geneoscopy's at-home test for colorectal cancer screening ColoSense is available in the US.
The test is being offered via a commercial collaboration with Geneoscopy, Labcorp said, adding that it expands its line of colorectal cancer screening products.
The test is covered for eligible Medicare and Medicare Advantage beneficiaries, and commercial coverage is also available, Labcorp said.